The Food and Drug Administration (FDA) issued guidance for industry entitled “PET Drug Applications – Content and Format for NDAs and ANDAs.”

The guidance is intended to assist the manufacturers of certain PET drugs – FDG, ammonia N 13, and sodium fluoride F 18 – in submitting NDAs and ANDAs in accordance with FDA regulations. In order to continue to market PET drugs for clinical use, manufacturers must submit NDAs or ANDAs by December 12, 2011.

In addition to the guidance for filing the applications, FDA has provided sample formats for the Chemistry, Manufacturing, and Controls (CMS) section.

To view the final guidance, please visit: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM078738.pdf

To view the sample formats for the CMC section, please visit: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM078740.pdf

This entry was posted in PET Drugs. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s